BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11549427)

  • 1. Willingness-to-pay for colorectal cancer screening.
    Frew E; Wolstenholme JL; Whynes DK
    Eur J Cancer; 2001 Sep; 37(14):1746-51. PubMed ID: 11549427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of two methods for eliciting contingent valuations of colorectal cancer screening.
    Whynes DK; Frew E; Wolstenholme JL
    J Health Econ; 2003 Jul; 22(4):555-74. PubMed ID: 12842315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eliciting willingness to pay: comparing closed-ended with open-ended and payment scale formats.
    Frew EJ; Whynes DK; Wolstenholme JL
    Med Decis Making; 2003; 23(2):150-9. PubMed ID: 12693877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Willingness to Pay for Colorectal Cancer Screening and Effect of Copayment in Southern Thailand.
    Saengow U; Birch S; Geater A; Chongsuwiwatvong V
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1727-1734. PubMed ID: 29938473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The measurement of willingness to pay for mass cancer screening with whole-body PET (positron emission tomography).
    Yasunaga H; Ide H; Imamura T; Ohe K
    Ann Nucl Med; 2006 Aug; 20(7):457-62. PubMed ID: 17037277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness to pay for diagnostic technologies: a review of the contingent valuation literature.
    Lin PJ; Cangelosi MJ; Lee DW; Neumann PJ
    Value Health; 2013; 16(5):797-805. PubMed ID: 23947973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass population screening for colorectal cancer: factors influencing subjects' choice of screening test.
    Frew E; Wolstenholme J; Whynes D
    J Health Serv Res Policy; 2001 Apr; 6(2):85-91. PubMed ID: 11357249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public's Willingness to Pay Towards a Medical Device for Detecting Foot Ulceration in People with Diabetes.
    Yang F; Gannon B; Weightman A
    Appl Health Econ Health Policy; 2018 Aug; 16(4):559-567. PubMed ID: 29948927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing willingness-to-pay: bidding game format versus open-ended and payment scale formats.
    Frew EJ; Wolstenholme JL; Whynes DK
    Health Policy; 2004 Jun; 68(3):289-98. PubMed ID: 15113640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does attribute framing in discrete choice experiments influence willingness to pay? Results from a discrete choice experiment in screening for colorectal cancer.
    Howard K; Salkeld G
    Value Health; 2009; 12(2):354-63. PubMed ID: 18657102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Willingness to pay in treatment of bleeding disorders.
    Eastaugh SR
    Int J Technol Assess Health Care; 2000; 16(2):706-10. PubMed ID: 10932435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with colorectal cancer screening in a population-based study: the impact of gender, health care source, and time.
    Slattery ML; Kinney AY; Levin TR
    Prev Med; 2004 Mar; 38(3):276-83. PubMed ID: 14766109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential costs of flexible sigmoidoscopy-based colorectal cancer screening.
    Marshall JR; Fay D; Lance P
    Gastroenterology; 1996 Dec; 111(6):1411-7. PubMed ID: 8942718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Planning for a possible national colorectal cancer screening programme.
    Garvican L
    J Med Screen; 1998; 5(4):187-94. PubMed ID: 9934649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening sigmoidoscopy for colorectal cancer.
    Scholefield JH; Moss S
    Lancet; 2003 Oct; 362(9391):1167-8. PubMed ID: 14568733
    [No Abstract]   [Full Text] [Related]  

  • 17. Determinants of willingness to pay for a new therapy in a sample of menopausal-aged women.
    Rasch A; Hodek JM; Runge C; Greiner W
    Pharmacoeconomics; 2009; 27(8):693-704. PubMed ID: 19712011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
    Hu SW; Holt EW; Husni ME; Qureshi AA
    Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summaries for patients. Screening for colorectal cancer: recommendations from the United States Preventive Services Task Force.
    Ann Intern Med; 2002 Jul; 137(2):I38. PubMed ID: 12118986
    [No Abstract]   [Full Text] [Related]  

  • 20. Willingness to pay to assess patient preferences for therapy in a Canadian setting.
    Marra CA; Frighetto L; Goodfellow AF; Wai AO; Chase ML; Nicol RE; Leong CA; Tomlinson S; Ferreira BM; Jewesson PJ
    BMC Health Serv Res; 2005 Jun; 5():43. PubMed ID: 15941474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.